CompletedNot Applicable

Biliary Obstruction of Neoplastic Origin Treated With Drainage. A Prognostic Study.

France372 participantsStarted 2021-07-15

Plain-language summary

Inclusion of patients with biliary drainage for inoperable malignant biliary obstruction and analysis of clinico-biological parameters

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Malignant Biliary obstruction : cholestasis (elevated bilirubin \> 40 µmol/L or alkaline phosphatase \> 1.5 time than the normal value) and dilation of biliary tract Exclusion Criteria: * Benign obstruction * Post stent surgery * First stent placed outside Brest University Hospital

What they're measuring

Short-term survival after biliary drainage

Timeframe: 4 years and fifth months

Trial details

NCT IDNCT06552208

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-07-15

View on ClinicalTrials.gov More Malignant Biliary Obstruction trials